These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 7442612)
21. Bone marrow depression due to chloramphenicol. Das PK; Chatterjee SC J Indian Med Assoc; 1967 Mar; 48(5):231-4. PubMed ID: 6039394 [No Abstract] [Full Text] [Related]
22. Aplastic anemia. Beckman H Wis Med J; 1967 Sep; 66(9):422-6. PubMed ID: 6075106 [No Abstract] [Full Text] [Related]
23. Aplastic anemia following chloramphenicol therapy still happens! Lepow ML Pediatrics; 1986 Jun; 77(6):932-3. PubMed ID: 3714393 [No Abstract] [Full Text] [Related]
24. [Blood dyscrasia following use of chloramphenicol]. Ruvidić R; Rolović Z; Perović Lj; Obradović D Srp Arh Celok Lek; 1969 May; 97(3):281-90. PubMed ID: 5198747 [No Abstract] [Full Text] [Related]
25. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. Flach AJ Am J Ophthalmol; 1982 Sep; 94(3):420-2. PubMed ID: 7124889 [No Abstract] [Full Text] [Related]
26. Is it time to stop using chloramphenicol on the eye? Prospective study of aplastic anaemia should give definitive answer. Gordon-Smith EC; Marsh JC; Geary CG BMJ; 1995 Aug; 311(7002):451. PubMed ID: 7640600 [No Abstract] [Full Text] [Related]
27. Blood dyscrasias attributed to chloramphenicol. A review of 576 published and unpublished cases. Polak BC; Wesseling H; Schut D; Herxheimer A; Meyler L Acta Med Scand; 1972 Nov; 192(5):409-14. PubMed ID: 5083381 [No Abstract] [Full Text] [Related]
28. Aplastic anemia after parenteral chloramphenicol: warning renewed. Plaut ME; Best WR N Engl J Med; 1982 Jun; 306(24):1486. PubMed ID: 7078596 [No Abstract] [Full Text] [Related]
29. [3 cases of blood dyscrasia following treatment with chloramphenicol]. von Rechenberg HK; Batz K Praxis; 1966 Feb; 55(8):214-6. PubMed ID: 5953269 [No Abstract] [Full Text] [Related]
34. Chloramphenicol eye drops and blood dyscrasia. McGuinness R Med J Aust; 1984 Mar; 140(6):383. PubMed ID: 6700500 [No Abstract] [Full Text] [Related]
35. Topical application of chloramphenicol eye ointment followed by fatal bone marrow aplasia. Brodsky E; Biger Y; Zeidan Z; Schneider M Isr J Med Sci; 1989 Jan; 25(1):54. PubMed ID: 2925363 [No Abstract] [Full Text] [Related]
36. [Aplastic anemia caused by chloramphenicol]. Popadić M; Surbat G Med Arh; 1968; 22(5):33-7. PubMed ID: 5194588 [No Abstract] [Full Text] [Related]
37. Fatal aplastic anemia and chloramphenicol. Clarke WT Can Med Assoc J; 1967 Sep; 97(13):815. PubMed ID: 6050902 [No Abstract] [Full Text] [Related]
38. Trends in ophthalmic antimicrobial utilization pattern in Bahrain between 1993 and 2000: a resurgence of chloramphenicol? Jassim Al Khaja KA; Sequeira RR; Mathur VS Int J Clin Pharmacol Ther; 2003 Jan; 41(1):36-41. PubMed ID: 12564744 [TBL] [Abstract][Full Text] [Related]
39. The clinical use of chloramphenicol. Snyder MJ; Woodward TE Med Clin North Am; 1970 Sep; 54(5):1187-97. PubMed ID: 4919149 [No Abstract] [Full Text] [Related]
40. [Blood dyscrasia in chloramphenicol therapy. A case of fatal aplastic anemia]. Mjos OD; Wraamann KN Tidsskr Nor Laegeforen; 1966 Sep; 86(18):1267-8. PubMed ID: 5915491 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]